| Laurus Labs Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 540222 |
NSE Symbol : LAURUSLABS |
P/E(TTM) : 126.07 |
|
ISIN Demat : INE947Q01028 |
Div & Yield% : 0.10 |
EPS(TTM) : 16.15 |
|
Book Value(₹) : 97.20 |
Market Cap(₹Cr) : 110,007.57 |
Face Value(₹) : 2.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 1,757.16 | 1,580.30 | 1,509.42 | 1,566.60 | 1,432.75 | 1,650.01 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1,757.16 | 1,580.30 | 1,509.42 | 1,566.60 | 1,432.75 | 1,650.01 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 20.07 | 13.09 | 14.37 | 28.45 | 21.52 | 72.16 |
| Total Income | 1,777.23 | 1,593.39 | 1,523.79 | 1,595.05 | 1,454.27 | 1,722.17 |
| Total Expenditure | 1,258.10 | 1,204.94 | 1,163.56 | 1,176.94 | 1,105.37 | 1,255.18 |
| PBIDT | 519.13 | 388.45 | 360.23 | 418.11 | 348.90 | 466.99 |
| Interest | 35.20 | 33.91 | 31.48 | 33.68 | 43.89 | 48.60 |
| PBDT | 483.93 | 354.54 | 328.75 | 384.43 | 305.01 | 418.39 |
| Depreciation | 95.76 | 95.17 | 94.31 | 95.59 | 93.57 | 88.19 |
| Tax | 103.25 | 68.50 | 69.03 | 87.93 | 59.66 | 82.07 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -5.04 | -0.92 | -9.67 | -14.76 | -6.16 | -3.77 |
| Reported Profit After Tax | 289.96 | 191.79 | 175.08 | 215.67 | 157.94 | 251.90 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 289.96 | 191.79 | 175.08 | 215.67 | 157.94 | 251.90 |
| EPS (Unit Curr.) | 5.37 | 3.55 | 3.25 | 3.99 | 2.93 | 4.68 |
| EPS (Adj) (Unit Curr.) | 5.37 | 3.55 | 3.25 | 3.99 | 2.93 | 4.68 |
| Calculated EPS (Unit Curr.) | 5.37 | 3.55 | 3.24 | 4.00 | 2.93 | 4.67 |
| Calculated EPS (Adj) (Unit Curr.) | 5.37 | 3.55 | 3.24 | 4.00 | 2.93 | 4.67 |
| Calculated EPS (Ann.) (Unit Curr.) | 21.47 | 14.21 | 12.97 | 15.98 | 11.70 | 18.69 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 21.47 | 14.21 | 12.97 | 15.98 | 11.70 | 18.69 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 40.00 | 0.00 | 0.00 |
| Equity | 108.05 | 107.97 | 107.97 | 107.96 | 107.96 | 107.85 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 4,810.44 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 29.54 | 24.58 | 23.87 | 26.69 | 24.35 | 28.30 |
| PBDTM(%) | 27.54 | 22.43 | 21.78 | 24.54 | 21.29 | 25.36 |
| PATM(%) | 16.50 | 12.14 | 11.60 | 13.77 | 11.02 | 15.27 |
